MétaCan
Menu
Back to cohort
Record W3036427315 · doi:10.1158/1078-0432.ccr-20-0103

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

2020· article· en· W3036427315 on OpenAlexafffund
Aline Talhouk, Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu, Stefan Kommoss, Huei San Leong, Stephanie Chen, Maria P. Intermaggio, C. Blake Gilks, Tayyebeh M. Nazeran, Mila Volchek, Wafaa Elatre, Rex C. Bentley, Janine Senz, Amy Lum, Veronica Chow, Hanwei Sudderuddin, Robertson Mackenzie, Samuel C.Y. Leong, Geyi Liu, Dustin Johnson, Billy Chen, Jennifer Alsop, Susana Banerjee, Sabine Behrens, Clara Bodelón, Alison H. Brand, Louise A. Brinton, Michael E. Carney, Yoke-Eng Chiew, Kara L. Cushing‐Haugen, Cezary Cybulski, Darren Ennis, Sián Fereday, Renée T. Fortner, Jesús García-Donás, Aleksandra Gentry‐Maharaj, Rosalind Glasspool, Teodora Goranova, Casey S. Greene, Paul Haluska, Holly R. Harris, Joy Hendley, Brenda Y. Hernandez, Esther Herpel, Mercedes Jimenez‐Liñan, Chloe Karpinskyj, Scott H. Kaufmann, Gary L. Keeney, Catherine J. Kennedy, Martin Köbel, Jennifer M. Koziak, Melissa C. Larson, Jenny Lester, Liz-Anne Lewsley, Jolanta Lissowska, Jan Lubiński, Hugh Luk, Geoff Macintyre, Sven� Mahner, Iain A. McNeish, Janusz Menkiszak, Nikilyn Nevins, Ana Osório, Oleg Oszurek, José Palacios, Samantha Hinsley, Celeste Leigh Pearce, Malcolm C. Pike, Anna Piskorz, Isabelle Ray‐Coquard, Valerie Rhenius, Cristina Rodríguez‐Antona, Raghwa Sharma, Mark E. Sherman, Dilrini De Silva, Naveena Singh, Hans‐Peter Sinn, Dennis J. Slamon, Honglin Song, Helen Steed, Euan A. Stronach, Pamela J. Thompson, Aleksandra Tołoczko, Britton Trabert, Nadia Traficante, Chiu-Chen Tseng, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Boris Winterhoff, Alicia Beeghly‐Fadiel, Javier Benı́tez, Andrew Berchuck, James D. Brenton, Robert Brown, Jenny Chang‐Claude, Georgia Chenevix‐Trench, Anna DeFazio, Peter A. Fasching, María J. García, Simon A. Gayther, Marc T. Goodman, Jacek Gronwald, Michelle J. Henderson, Beth Y. Karlan, Linda E. Kelemen, Usha Menon, Sandra Oršulić, Paul D.P. Pharoah, Nicolas Wentzensen, Anna H. Wu, Joellen M. Schildkraut, Mary Anne Rossing, Gottfried E. Konecny, David G. Huntsman, Ruby Yun‐Ju Huang, Ellen L. Goode, Susan J. Ramus, Jennifer A. Doherty, David D.L. Bowtell, Michael S. Anglesio

Bibliographic record

VenueClinical Cancer Research · 2020
Typearticle
Languageen
FieldMedicine
TopicOvarian cancer diagnosis and treatment
Canadian institutionsRoyal Alexandra HospitalBC Cancer AgencyFoothills Medical CentreCanadian Centre for Applied Research in Cancer ControlVancouver General HospitalAlberta Health ServicesUniversity of British Columbia
FundersNational Cancer InstituteCancer Council TasmaniaCancer Council VictoriaHorizon 2020 Framework ProgrammePeter MacCallum FoundationBC Cancer FoundationUniversity College London Hospitals NHS Foundation TrustMedical Research and Materiel CommandEisaiCanada Excellence Research Chairs, Government of CanadaBundesministerium für Bildung und ForschungCanada Research ChairsCanadian Institutes of Health ResearchCancer Institute NSWCancer AustraliaMayo ClinicOvarian Cancer ActionMichael Smith Health Research BCNational Health and Medical Research CouncilAstraZenecaInvitaeDaiichi-SankyoMacroGenicsNational Institute for Health and Care ResearchClovis OncologyCancer Research UKUniversity College LondonCancer Council NSWOvarian Cancer AustraliaNational Institutes of HealthDr. Miriam and Sheldon G. Adelson Medical Research FoundationCelgeneCarrick TherapeuticsIgnytaU.S. Department of DefenseEli Lilly and CompanyCancer Council South AustraliaDeutsches KrebsforschungszentrumPfizerEuropean CommissionBreast Cancer Research FoundationAmerican Oil Chemists' SocietyNational Center for Advancing Translational SciencesMedical Research CouncilTeva Pharmaceutical IndustriesAmerican Cancer Society
KeywordsSerous fluidOvarian carcinomaSerous carcinomaOncologyOvarian cancerSerous ovarian cancerGene expressionGene expression profilingClinical trialInternal medicineGeneMedicineBioinformaticsBiologyCancerGenetics

Abstract

fetched live from OpenAlex

Abstract Purpose: Gene expression–based molecular subtypes of high-grade serous tubo-ovarian cancer (HGSOC), demonstrated across multiple studies, may provide improved stratification for molecularly targeted trials. However, evaluation of clinical utility has been hindered by nonstandardized methods, which are not applicable in a clinical setting. We sought to generate a clinical grade minimal gene set assay for classification of individual tumor specimens into HGSOC subtypes and confirm previously reported subtype-associated features. Experimental Design: Adopting two independent approaches, we derived and internally validated algorithms for subtype prediction using published gene expression data from 1,650 tumors. We applied resulting models to NanoString data on 3,829 HGSOCs from the Ovarian Tumor Tissue Analysis consortium. We further developed, confirmed, and validated a reduced, minimal gene set predictor, with methods suitable for a single-patient setting. Results: Gene expression data were used to derive the predictor of high-grade serous ovarian carcinoma molecular subtype (PrOTYPE) assay. We established a de facto standard as a consensus of two parallel approaches. PrOTYPE subtypes are significantly associated with age, stage, residual disease, tumor-infiltrating lymphocytes, and outcome. The locked-down clinical grade PrOTYPE test includes a model with 55 genes that predicted gene expression subtype with >95% accuracy that was maintained in all analytic and biological validations. Conclusions: We validated the PrOTYPE assay following the Institute of Medicine guidelines for the development of omics-based tests. This fully defined and locked-down clinical grade assay will enable trial design with molecular subtype stratification and allow for objective assessment of the predictive value of HGSOC molecular subtypes in precision medicine applications. See related commentary by McMullen et al., p. 5271

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.498
Threshold uncertainty score0.254

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.181
GPT teacher head0.430
Teacher spread0.249 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations75
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueClinical Cancer ResearchSame topicOvarian cancer diagnosis and treatmentFrench-language works237,207